Trump's win triggers rush for emergency contraception in U.S.
Donald Trump won the presidential election in the United States. In January, he will move into the White House for the second time. The effects of the takeover are already visible. American women have rushed to pharmacies en masse, purchasing emergency contraception.
14 November 2024 13:27
Donald Trump, as he stated, has achieved his goal. He won the presidential election, defeating Democrat Kamala Harris. After a four-year break, he will return to the White House. This will be his second and final term. The emotions associated with the right-wing politician are stirring people around the world, particularly the residents of the United States, which is understandable. "The Trump Effect" is evident even now, even though he will assume office only in January 2025. This phenomenon mainly concerns emergency contraception.
It is no secret that Donald Trump holds very extreme views on the issue of abortion and women's rights. He does not hide his desire for a complete ban on abortion. It can be assumed that he will do everything possible also to restrict access to emergency contraception, which is currently legal in the USA. This situation has alarmed women in the United States, prompting them to rush to pharmacies en masse.
"The Trump Effect" already visible in the USA
American women fear that when Donald Trump officially becomes president, access to emergency contraception will be restricted. Women have hurried to pharmacies to stock up accordingly. This is most noticeable in states where abortion rights are already prohibited. The online pharmacy Winx Health reported that within the first 60 hours after the elections, sales of the Restart pill surged by over 990 percent compared to the previous week.
The trend extends beyond pills. There's a notable increase in interest in permanent contraceptive methods. The non-profit organization Planned Parenthood announced on social media that from Wednesday, November 6, the number of visits for the insertion of an intrauterine device increased by 760 percent, and visits for the implantation of contraceptive implants rose by 350 percent.